HK) were cultivated in embryonated chicken eggs, and virus-containing allantoic fluid was titrated for hemagglutination (HA) activity before use.
To: Generation and Assay. CBA Tc were generated after intranasal priming of mice with A/ X-31 and a secondary in vitro culture with A/USSR-infected lymphoblasts as previously described (10) . CBA lymphoblasts stimulated for 2 d with Escherichia coli lipopolysaccharide served as target cells after a 5-h infection with A/X-31 virus (for virus infection of cells, see below). 51Cr-labeled target cell lysis was assayed in flat microplates at various ratios of killer: target cells (11) for 3 h. Antisera were absorbed with B/HK-infected P815 cells before incubation with the target cells. All wells contained the same volume (0.22 ml).
Monoclonal Antibodies. Hybrid cell line 174, which forms antibodies to M-protein, was selected after fusion of myeloma cells P3/X-63-Ag8 with immune spleen cells according to the method of K6hler and Milstein (12) . The spleen cell donor was a CBA mouse that was immunized with two intramuscular injections of purified M-protein from A/USSR virus (13) in complete Freund's adjuvant. Fusion was carried out 4 d after an intraperitoneal boost injection (150/xg of M-protein). The hybridoma cells were cloned and grown as solid tumors in (CBA × BALB/c)FI mice. The specificit3YsOf the antibody for influenza and M-protein was established by immunoprecipitation of S-labeled virus proteins and polyacrylamide gel electrophoresis.
Virus Infection of Cells. P815 mastocytoma cells were maintained by passage in (CBA X DBA)F1 mice. In vitro culture done was in RPMI-1640 medium (Grand Island Biological Co., Grand Island, N. Y.) that contained 10% heat-inactivated fetal calf serum (RPMI/10). 107 P815 cells were infected with 800 HA U of influenza virus in 1 ml of RPMI-1640 medium. After 1 h at 37°C, the cells were washed and incubated at 2 × 106/ml in RPMI/10 at 37°C for up to 6 h or at 33°C for 16 h (10).
Virus replication was prevented in certain experiments by actinomycin D (14) : cells were preincubated with actinomycin (1 ~g/ml) for 1 h, then infected with A-virus in the presence of the inhibitor at 1/lg/ml. Virus was inactivated by UV light: virus (1.5 ml of X-31-containing allantoic fluid) was treated for 4 min at 25 cm from a Philips 25-W germicidal bulb (Philips Electronic Instruments, Inc., Mahwah, N. J.). An infectivity check of this UV-treated virus by passaging twice through embryonated chicken eggs showed greatly reduced viral growth; however, slight infectivity could still be detected.
Plasma Membrane Preparations.
The methods of Crumpton and Snary (15) and Bridgen et al. (16) were used. 16-h-infected (X-31) P815 cells (109 cells) were fractionated by differential centrifugation and discontinuous sucrose density gradients after disruption with a Stansted pump (Stansted Fluid Power Ltd., Essex, England). Control cells (5 × l0 s cells) were infected with X-31 virus 1 h before disruption. While endoplasmic reticulum (e.r.) was pelleted, plasma membranes were recovered at the 25-36% sucrose-band interface after centrifugation at 22,000 rpm for 18 h in a Beckman SW41 rotor (Beckman Instruments Inc., Spinco. Div., Palo Alto, Calif.). Membrane fractions were washed and solubilized in 0.25 ml 2% sodium deoxycholate, 10 mM Tris, pH 8.2, with phenylmethylsulfonyl fluoride present. M-protein content in the lysed membrane fractions was determined by direct, solid-phase microradioimmunoassay.
Solid-Phase Radioimmunoassay. For the detection and quantitation of M-protein or antibodies to M-protein flexible plastic plates (Cooke Engineering Co., Alexandria, Va.) were coated with purified M-protein, detergent-solubilized membranes, or disrupted virus according to the general procedure of Rosenthal et al. (17) . Antigens were dried onto the wells overnight at 37°C, then briefly fixed with methanol. Indirect binding assays used the appropriate 12sI-labeled goat anti-rabbit immunoglobulin or rabbit anti-mouse antiserum. Direct assays were with the IgG2 fraction of x25I-labeled monoclonal anti-M antibody. Radiolabeled antisera were allowed to react for 15 h at 4°C. The plates were washed, and the wells were separated to count the radioactive antibody bound.
The M-protein content of purified membranes was quantitated by direct solid-phase radioimmunoassay. Binding of I2SI-monoclonal anti-M to serial dilutions of the membrane lysates (in phosphate-buffered saline [PBS]/I% bovine serum albumin [BSA] ) and of the purified M-protein standard (from 1 mg/ml) dried into wells was compared. (18) and 125I-labeled as previously described. 28% of the l~SI-antibody bound to M-protein on plastic dishes and wells that were coated with detergent-disrupted type-A viruses. Quantitative binding of antibody to cells was assayed as described before (19) . P815 cells at 2 × 105/0.1 ml (virus-infected or uninfected controls) were incubated for 90 min at 20°C with increasing concentrations of radiolabeled antibody (2.5 × 10-3-1 X 10 ~/xg/0.1 ml) in Hepes-buffered RPMI-1640 that contained 1.7% BSA and 0.1% NaNa. Cells were washed twice, and radioactivity in the cell pellets was counted. Binding data obtained with monoclonal antibody were evaluated by the Scatchard equation as described in a previous report (19) . A graph of moles of antibody bound per moles of cells vs. moles of antibody bound per moles of free antibody × moles of cells yielded linear plots with a slope equal to the binding affinity constant (Ka) and the x-intercept equal to the number of antigenic sites per cell. All quantitation of viral antigens on infected cell surfaces was done by Scatchard analysis.
Expression of HA on infected cells was assayed by monoclonal antisera directed against H 1 (clone W18/1) or H3 (clone 3/1) of type-A viruses (20, 21) . After fractionation on a protein-ASepharose column, the active IgG2a fractions (determined by HA inhibition titration) were radiolabeled and used in equilibrium binding studies as above.
Complement-mediated Lysis of Virus-infected Cells. 51Cr-labeled virus-infected cells were incubated with diluted antibody for 30 min at 4°C. The cells had been infected for 16 h with A/X-31 or B/HK virus. After one wash they were resuspended in 1:1 RPMI-1640 medium with 1% fetal calf serum guinea pig complement (absorbed with agarose, diluted 1:3 in PBS) and incubated at 37°C for 1 h. Cells were then pelleted by centrifugation, and aliquots of the supernates were counted for radioactivity. All antisera used had been previously absorbed with B/Hong Kong-infected target cells. 15 M NaCI, and 0.25% BSA) with 100 ~1 of labeled viral antigens diluted to 50,000 cpm/100/~1. The reaction mixture was incubated for 2 h at 25°C and then centrifuged at 800 g for 15 rain. This was necessary to prevent labeled M-protein from adhering nonspecifically to precipitates. 50 btl of a 1/5 dilution of a rabbit anti-mouse Ig mixture was incubated for 2 h at 25°C, then overnight at 4°C. Precipitates were washed three times with RIP buffer and dissolved in 25 /zl of polyacrylamide gel electrophoresis (PAGE) sample buffer that contained 10% 2-mercaptoethanol. Immunoprecipitates were analyzed by 8% sodium dodecyl sulfate-PAGE as described by Laemmli (22) for 15 h at 70 V. The gels were processed for fluorography and exposed to Kodak XR-5 film (Eastman Kodak Co., Rochester, N. Y.) for 20 h.
Preparation of Labeled Virus

Results
Specificity of Monoclonal Antibodies to M-Protein. The monoclonal anti-M (174) is an
IgG2 antibody and can be efficiently fractionated on staphylococcal protein-A- Sepharose columns (Materials and Methods). The resulting antibody fraction interacts with M-protein of influenza virus A/X-31, but not with that of B/HK (Fig. 1) . It has equally high reactivity with all other type-A viruses tested (USSR, A/Jap/Bel, WSN, and Jap 305; data not illustrated). The antibody specificity was verified by immunoprecipitation of ~S-labeled viral proteins and PAGE. Fig. 2 shows that reaction of the monoclonal antibody is restricted to M-protein alone.
Quantitation of M-Protein in Solubilized Membranes Purified from A/X-31 Virus-infected
P815 Cells. Because our antibody is monoclonal it was important to ascertain that the low number of M-protein sites detected on the surface of infected cells could not simply be attributed to the possibility that the antibody interacts with a part of the M-protein molecule that is poorly accessible on intact cells. For this reason we purified plasma membranes and e.r. from P815 cells infected 16 h with X-31 virus and estimated the content of membrane-associated M-protein in detergent lysates, which would include both surface and internal M-protein. Cells in contact with the virus 1 h, without further virus replication, served as control. Radioimmunoassay of the solubilized fractions (Fig. 3) shows that membranes isolated from 16-h-infected cells bind small but significant amounts of lZ~I-monoclonal anti-M, whereas control cell actinomycin D to prevent virus replication (14) , showed far less antibody binding. The transient low binding of anti-M-protein soon after cell treatment (which suggested < 100 M-protein sites) can probably be assigned to rupture of virus, because after 16 h of incubation there was no detectable specific binding of anti-M. Although the number of M-protein sites on the surface of cells infected for 16 h is only -108, virus replication is required for the appearance of M-protein, and it does appear to be synthesized by the host cell.
Expression of HA on Virus-infected Cells.
We measured viral HA on 16-h infected cells to confirm that our conditions of infection and incubation permitted normal expression of virus proteins on the cell surface. Quantitative binding studies with radiolabeled monoclonal antibodies (Table II) (Table III ). The monoclonal anti-H-2 on its own partially inhibits cytotoxicity, but this inhibition is not enhanced by anti-M.
Complement-mediated Lysis of A-Virus-infected Cells by Antibodies to Viral Proteins. P815
cells were infected overnight with A/X-31, and complement-mediated lysis by monoclonal and heterogeneous antisera from rabbits hyperimmunized with M-protein was assayed. Cell lysis was observed with rabbit antiserum to M-protein, even after absorption of the serum with B/HK-infected P815 cells. On the other hand, the monoclonal anti-M-protein failed to effect lysis of infected cells, although the antibody 174 is an IgG2a, which should fix complement (Fig. 4) . This finding does not permit final conclusions. It could be a result of the low number of M-protein sites on infected cells or of the fact that monoclonal antibodies do not necessarily lyse cells with complement. We obtained similar results with monoclonal anti-HA antibodies. IgG2a Howard and Corvalan (23) also found that not all monoclonal antibodies to rat histocompatibility antigens, though able to fix complement, will lyse cells. Discussion Accurate quantitation of M-protein on influenza virus-infected target cells is important for assessment of the role of that antigen in recognition by cross-reactive To. We have recently selected a hybridoma secreting monoclonal anti-M to pursue this question. The monoclonal anti-M-protein antibody 174 has the advantage of monospecificity, which could not be fully ascertained with heterogeneous hyperimmune antisera used in the past. The monoclonal serum shows no cross-reactivity with other A-virus proteins or with cells infected with type-B influenza viruses. In addition, the high-titer hybridoma serum can be readily purified to yield an IgG2 fraction of high antibody content and a Ka of 1-2 × 109 liter/mol (9), thereby facilitating quantitative binding studies.
In our preliminary studies (9) we detected very low levels of specific binding of the monoclonal anti-M to P815 cells infected up to 16 h with different type-A viruses. Only when nonspecific binding was deducted could saturation of M-sites by the antibody become evident. Scatchard plots of the binding data showed that a maximum of 2-3 × 103 M-protein molecules appear on each P815 cell surface infected for 16 h with different type-A viruses. This is much lower than the 105-106 sites estimated by Ada and Yap (8). Our figure does not result from any generally reduced protein synthesis under our infection conditions, because high levels of HA expression (>105 molecule/surface of each cell) were readily obtained; and, typically, 65-75% of the infected P815 cells can be lysed specifically by Tc (10) .
Another possibility, that the epitope on the M-protein detected by our monoclonal anti-M is poorly accessible on the cell surface, is ruled out by studies with solubilized, purified cell membranes. In the lysates, all M-protein molecules (internal and external) should be available to the antibody, yet we do not see the two to three order of magnitude increase that would be suggested by the values of Ada and Yap (8) . Instead, radioimmunoassay detected the equivalent of ~ 1.9 × 104 molecule/cell in the plasma membrane lysate, and 3.1 × 104 molecule/cell in the e.r. fraction. Adjustment of these values for estimated recovery of total membrane protein increases the figures to ~3.8 × 104 and 6.2 × 104 molecule/cell in these respective fractions, assuming a 50% yield as suggested by the data of Crumpton and Snary (15) with <1010 Bristol-8 lymphoblastoid cells. Our samples (5 × 108 and 10 9 cells) were disrupted and purified according to their procedures. The 10-or 20-fold higher Mcontent of lysed plasma membranes compared with infected cells is consistent with the view (24) that M-protein is localized principally on the cytoplasmic side of the host cell plasma membrane. M-protein is also found in internal membrane fractions (24) , as is the case in our e.r. fraction. Because only a small fraction of the M-protein associated with plasma membranes is found on the surface of the P815 cells even after a long period of infection, we examined the possibility that the surface M-protein might have originated from ruptured input virus that was exposed on the cell membrane as incubation progressed. Our findings with actinomycin D treatment and UV-inactivated virus show that virus replication is indeed required for cell surface M-protein appearance. This, and evidence from kinetic studies of M-protein appearance on infected P815 cells (9) , indicate that the external M-protein detected in these studies is synthesized within the host cell. However, we have no direct evidence that M-protein is expressed as a membrane protein in the same sense as for the viral glycoproteins. The possibility remains that some slight amount of virus budding or rupture of partially assembled virions could be the source of the surface M-protein.
The study of complement-mediated lysis of infected target cells with monoclonal antisera of viral protein was inconclusive. Monoclonal anti-M-protein did not promote lysis, even though it is of the IgG2 class and should be capable of fixing guinea pig complement. Although we know that >10 s HA molecules are expressed on the cell surface, the monoclonal anti-HA 74/6 (IgM) was effective, whereas the 3/1 anti-HA (IgG2a) killed only very slightly, if at all (Fig. 4) . It is clear that complementdependent lysis is less sensitive than antibody-binding studies in detection of cell surface antigens, that monoclonal antibodies, in particular, vary in their ability to cause complement-mediated cell lysis as reported by Howard and Corvalan (23) . In confirmation of earlier results by Biddison et al. (6) , our studies with hyperimmune rabbit anti-M (which had been preabsorbed by B/Hong Kong-infected P815 cells) showed that it could bind to and promote complement-mediated lysis of 16-h A-virusinfected P815 cells. However, because of the heterogeneous nature of this antiserum, lysis of infected targets is not adequate proof that M-protein is integrated as a membrane protein in the host cell surface. The use of such a heterogeneous serum is the most likely explanation of the estimates of Ada and Yap (8) , which differ so markedly from ours. Because the specificities of heterogeneous antibodies are not well defined (and might not be detected by immunodiffusion tests), possible low crossreactivity with other virus components or antigens on infected cells cannot be completely ruled out. Ada and Yap (8) reported it difficult to purify antibody from the hyperimmune antisera (anti-M-protein or anti-HA) and therefore found <2% of added radioactivity bound to infected cells. In contrast, our radiolabeled monoclonal probes all showed a minimum of 20% binding under conditions of antigen excess. Finally, our quantitation of surface viral antigens is by extrapolation of linear Scatchard plots of the antibody-binding data to saturation, which is an analysis that requires monoclonal antibody (19) . The central question regarding the possible recognition of M-protein by Tc crossreactive for different type-A influenza viruses is not yet resolved. P815 cells are excellent target cells for T cell lysis after a 3-or 16-h infection period. After 3 h, only 102 M-protein sites can be detected on infected P815 cells (9). We do not know how many antigenic sites are required to induce T cell killing. On the other hand, our findings concerning the low numbers of M-protein sites exposed on cells and the lack of inhibition of T cell cytotoxicity by antibodies to M-protein even in the presence of anti-H-2 leave in doubt that it is the M-protein that is recognized by To. Other evidence is accumulating that suggests that the cross-reactive T~ may have specificity for the homologous part of the HA molecules. Effros et al. (26) have provided evidence of the inhibition of T~ specific for the different subtypes of A-virus by antibodies to HA. We find that some (but not all) monoclonal antibodies to HA of type-A virus in combination with monoclonal antibodies to H-2 synergistically inhibit T cell-mediated lysis of infected target cells (25) .
Summary
Monoclonal antibody to type-A influenza virus matrix (M)-protein was used to quantitate the appearance of M-protein on abortively infected P815 cells. After 16 h of infection with different type-A viruses, only a low amount of M-protein appears on the surface of infected cells (~103 site/cell) in contrast to ~105 hemagglutinin molecules on each cell surface. However, virus replication is required for M-protein appearance. Analysis of solubilized membranes purified from 16-h-infected cells shows ~104 M-protein molecule/cell in the plasma membrane, a content that is consistent with the observed low surface expression, and that indicates that most of the Mprotein is localized internally. We found no evidence that cross-reactive cytotoxic T cells could recognize M-protein; neither monoclonal antibody nor hyperimmune anti-M-protein antiserum could inhibit T cell killing, either alone or in combination with monoclonal anti-H-2 antibody. Taken together, the low level of M-protein appearance and lack of T cell blocking by anti-M-protein antibody leaves doubt that M-protein is the antigen recognized by cross-reactive cytotoxic T cells.
